Lost in translation: neuropsychiatric drug development.

@article{Becker2010LostIT,
  title={Lost in translation: neuropsychiatric drug development.},
  author={Robert E. Becker and Nigel H Greig},
  journal={Science translational medicine},
  year={2010},
  volume={2 61},
  pages={
          61rv6
        }
}
  • Robert E. Becker, Nigel H Greig
  • Published in
    Science translational…
    2010
  • Medicine
  • Recent studies have identified troubling method and practice lapses in neuropsychiatric drug developments. These problems have resulted in errors that are of sufficient magnitude to invalidate clinical trial data and interpretations. We identify two potential sources for these difficulties: investigators selectively choosing scientific practices for demonstrations of efficacy in human-testing phases of drug development and investigators failing to anticipate the needs of practitioners who must… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 18 CITATIONS

    Economic demand predicts addiction-like behavior and therapeutic efficacy of oxytocin in the rat.

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Fire in the ashes: Can failed Alzheimer’s disease drugs succeed with second chances?

    VIEW 10 EXCERPTS
    CITES BACKGROUND & METHODS

    Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.

    VIEW 10 EXCERPTS
    HIGHLY INFLUENCED

    What Will Be the Psychotropic Drugs of Tomorrow

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Drug discovery and development: Role of basic biological research

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 76 REFERENCES

    Explanatory models for psychiatric illness.

    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    What the CATIE study means for clinical practice.

    VIEW 9 EXCERPTS
    HIGHLY INFLUENTIAL

    A method for estimating increased effect size and reduction of clinical trial costs

    • K. O. Cogger, Rating rater improvement
    • J. Clin. Psychopharmacol. 27, 418–420
    • 2007
    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL